newly
diagnosed
treatment
information
research &
trials
webcasts find
support
seminars
& meetings
events doctors nurses advocacy about
IMF
helping
the IMF
 
      treatment information     
  Share via del.icio.us Share via Digg
 
Publications:
10.23.06     Understanding Thalidomide Therapy
 
10.23.06     Understanding VELCADE® (bortezomib) for Injection Therapy
 
09.11.05     International Myeloma Foundation Patient Handbook - Hebrew Edition
 
Webcasts:
01.30.08     A Patient's Story
  Zipy Farber
01.30.08     The Founding of AMEN
  Paula Azulai
Chair of AMEN
01.30.08     Understanding Stem Cell Transplant
  Dr. Izhar Hardan
Chaim Sheba Medical Center at Tel Hashomer
Tel Aviv, Israel
01.29.08     What is Myeloma?
  Prof. Dina Ben-Yehuda
Department of Hematology
Hadassah University Hospital
Ein-Karem, Jerusalem
12.30.07     Dr. Rowe - Information From The 2007 Annual Meeting of the American Society of Hematology (ASH)
  Dr. Rowe provides a Hebrew language summary of the new scientific findings presented at the 2007 Annual Meeting of the American Society of Hematology (ASH)
12.17.06     Overview of ASH 2006 in Hebrew
  Dina Ben-Yehuda, MD
Hadassah University Hospital
Jerusalem, Israel
06.27.06     AMEN's First Anniversary
 

We thank our web site sponsors

Amgen

Binding Site

Celgene Corporation

Proteolix

We welcome our international partners:
Canada Czech Republic Europe Israel Japan Latin America
Copyright 2009. International Myeloma Foundation. All Rights Reserved.

International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
USA
phone: 800-452-2873 (US and Canada)
818-487-7455 (elsewhere)
fax: 818-487-7454
email: TheIMF@myeloma.org